Expert Outlook | New Myelofibrosis Therapies Showing Promise
https://vimeo.com/1020338609 What myelofibrosis therapies in development show promise? Dr. John Mascarenhas, a myelofibrosis researcher, reviews innovative treatments that are being combined with JAK inhibitors as well as single agent therapies…
Updates in Myelofibrosis Research From an Expert
https://vimeo.com/1020338673Dr. John Mascarenhas shares updates on myelofibrosis research. Dr. Mascarenhas highlights the shift towards combination therapies, particularly the use of JAK inhibitors alongside novel agents, with the goal of improving…
Considering a Myelofibrosis Clinical Trial? Questions You Should Ask
https://vimeo.com/928809660 What questions should patients ask when considering a myelofibrosis clinical trial? Expert Dr. Gabriela Hobbs discusses how clinical trials may fit into a treatment plan and shares key questions…
What Are the Currently Approved Myelofibrosis Therapies?
https://vimeo.com/928808656 Expert Dr. Gabriela Hobbs shares an overview of available therapies and important considerations when choosing a myelofibrosis treatment plan. Dr. Gabriela Hobbs is a hematology-oncology physician specializing in the…
Myelofibrosis Clinical Trial Participation | How Does It Move Research Forward?
https://vimeo.com/928808368 How do clinical trials move myelofibrosis research forward? Expert Dr. Gabriela Hobbs discusses the purpose of clinical trials, factors that may impact participation, and how trials can benefit patients….
Which Emerging Myelofibrosis Therapies Are Showing Promise?
https://vimeo.com/928806986 What are the latest advances in myelofibrosis therapy? Expert Dr. Gabriela Hobbs discusses various inhibitor therapies, including BET inhibitors, that are currently being studied in clinical trials for patients…
Primary vs Secondary Myelofibrosis | What’s the Difference?
https://vimeo.com/928806744 How are primary myelofibrosis and secondary myelofibrosis defined? Expert Dr. Gabriela Hobbs explains the differences between the conditions and discusses a common scenario that secondary myelofibrosis patients often experience. …
Evolving Myelofibrosis Treatment Options: What You Should Know
https://vimeo.com/925945364 Myelofibrosis treatment and care is evolving quickly so it’s essential to understand your options and work with your healthcare team when making treatment decisions. In this webinar, Dr. Gaby…
Evolving Myelofibrosis Treatment Options: What You Should Know Resource Guide
Download Resource Guide Download Resource Guide See More from Evolve Myelofibrosis
Choosing a Myelofibrosis Treatment Plan | Key Questions to Ask
https://vimeo.com/888888909 When considering therapy for myelofibrosis, where do you start? Dr. Lucia Masarova shares advice and key questions to ask your provider when making myelofibrosis treatment decisions. Dr. Lucia Masarova…
Is Stem Cell Transplant the Only Curative Option for Myelofibrosis?
https://vimeo.com/888889073 Is there a cure for myelofibrosis? Dr. Lucia Masarova explains the role of stem cell transplant for the treatment of myelofibrosis and reviews additional therapies for patients who do…
Myelofibrosis Therapies in Clinical Trials | BET Inhibitors
https://vimeo.com/888889142 What are BET inhibitors? Dr. Lucia Masarova, an MPN specialist and researcher, explains what BET inhibitors are and discusses the role these therapies may play in the treatment of…